Why I would buy and hold CSL and these ASX healthcare shares

Here's why I would buy and hold CSL Limited (ASX:CSL) and these ASX healthcare shares right now…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Due to favourable long term industry tailwinds, I'm particularly positive on the healthcare industry.

But with so many top shares to choose from in the industry, it can be difficult to decide which ones to buy.

To narrow things down I have picked out three ASX healthcare shares that I believe would be fantastic long term options for investors. They are as follows:

CSL Limited (ASX: CSL)

The first healthcare share I would buy is CSL. It is one of the world's leading biotherapeutics companies and has a portfolio of life-saving therapies and vaccines. Pleasingly, the company isn't resting on its laurels and is investing heavily in its research and development. This year I expect CSL to invest somewhere in the region of ~US$900 million into these activities. These annual investments mean the company has a large number of therapies in its pipeline that have the potential to generates significant sales over the next decade. Overall, I believe CSL is well-positioned to continue growing its earnings at a solid rate for the foreseeable future.

iShares Global Healthcare ETF (ASX: IXJ)

Another healthcare option for investors to consider is the iShares Global Healthcare ETF. It provides investors with exposure to companies across a range of sectors including biotechnology, pharmaceutical, and medical devices. This includes many of the world's biggest healthcare companies such as CSL, Johnson & Johnson, Novartis, and Pfizer. Given the increasing demand for healthcare services globally, I believe this group of companies could outperform the market over the long term. This could make it a quality option for investors.

Ramsay Health Care Limited (ASX: RHC)

Ramsay Health Care has been battling with tough trading conditions for a couple of years and things are unlikely to get easier in the immediate term. However, I believe this is already factored into the Ramsay share price. As a result, I think now is the time to focus on the long term. Which I believe looks very positive due to the expected increase in demand for healthcare services and its global footprint. In addition to this, Ramsay has a long history of growing through acquisitions. I suspect there could be more coming in the not so distant future, expanding the company's operations into new geographies.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

woman looking at iPhone whilst working on a laptop
Growth Shares

3 of the best Australian shares to buy and hold until 2035

It could be worth holding tightly to these shares for the long term.

Read more »

Two large bulls fight against each other in the dust.
Growth Shares

2 quality ASX 200 stocks to buy for your 2026 portfolio

Brokers are bullish on these mainstay sector picks.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »